Evaluation and Validation of a Crohn's Disease Inflammatory Activity Index Reflecting Pattern of Endoscopic Severity
- 1 January 1998
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 33 (3) , 283-288
- https://doi.org/10.1080/00365529850170874
Abstract
This study was designed to investigate objective variables assessing the inflammatory activity of Crohn's disease accessible for routine management and their suitability to act as surrogate indicators for endoscopic alterations. Thirty-six patients were included in a prospective study and underwent endoscopic investigation, 18 with clinically exacerbated disease and 18 after acute-phase conservative therapy. The endoscopic findings were classified to define the dependent variable, yielding two categoric levels: acute active disease and remission. The extent of affected mucosal area was not taken into consideration. The serum variables alpha1-antitrypsin, acid alpha1-glycoprotein (AGP), C-reactive protein (CRP), sialic acids, prealbumin (PAB), and albumin were used as independent variables to predict the dependent variable. To compare the results with common indices, the Crohn's Disease Activity Index (CDAI) and van Hees Index were calculated. The following model was calculated by stepwise logistic regression analysis: if AGP (mg/dl) -4.2 x PAB (mg/dl) > or =0.8, then endoscopically active disease will be predicted with a sensitivity of 100% and a specificity of 95% (P < 0.001). The predictive values of the single variables, CDAI, and van Hees Index were lower. For validation of results an analogous study was performed including 44 patients, 29 with active disease and 15 controls. The existence of the model was confirmed, again showing high values for sensitivity (86%) and specificity (100%). On a qualitative level focusing on clinical relevance, the endoscopic and biologic findings of Crohn's disease are highly associated. In addition to clinical assessment, usage of the developed index as a rationale contributing to therapeutic decisions in the short- and long-term management might be reasonable.Keywords
This publication has 16 references indexed in Scilit:
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- A Comparison of Budesonide with Prednisolone for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Faecal clearance of α1‐antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel diseaseJournal of Gastroenterology and Hepatology, 1991
- Clinical, biological, and endoscopic picture of attacks of Crohn's diseaseGastroenterology, 1990
- Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).Gut, 1989
- The Clinical Significance of Serum C Reactive Protein Levels in Crohnʼs DiseaseJournal of Clinical Gastroenterology, 1988
- Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.Gut, 1986
- Utilization of Prealbumin as a Nutritional ParameterJournal of Parenteral and Enteral Nutrition, 1985
- Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowelDigestive Diseases and Sciences, 1984
- Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.Gut, 1981